Tag Archives: Biotechnology Industry

Debunking Ag Biotech’s Top 5 Myths

Book

On Reason.com, award-winning science correspondent Ronald Bailey takes on the Institute for Responsible Technology (IRT), an organization opposed to crop biotechnology. IRT published a list of reasons to avoid GMOs. Bailey says, “it’s a mish-mash of misinformation and disinformation. All of the institute’s assertions are unfounded.” In a detailed article chock full of scientific cites, Bailey debunks the following IRT Myths: 1. “GMOs Are Unhealthy” 2. “GMOs Increase Herbicide Use” 3. “Genetic Engineering Creates Dangerous Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,

Despite Low Funding, Biotech Productivity Remains High In 2013

John Milligan

At the 2013 BIO CEO & Investor Conference, John Milligan, President and COO of Gilead Sciences, spoke in a standing room only fireside chat with Joel Sendek, Managing Director of Stifel Nicolaus, who moderated the discussion. Nicolaus noted that Gilead’s market cap has grown at an astounding 40 fold over the past 15 years, and asked Milligan to speak about the current state of the biotech industry. Milligan explained that biotech is not becoming more Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Word on the Street – Biotech Stocks Only Have Room to Go Up

The Opening Lunch Plenary at this year’s BIO CEO & Investor Conference was a lively discussion between portfolio managers and senior buy-side analysts looking to forecast the year ahead in biotech. BIO’s own, Celia Economides, Director, Investor Relations & Programs, reminded us all where we were 15 years ago at the inception of this event. At the 1999 event, there were 18 presenting companies, zero 1X1 meetings scheduled and 271 attendees.  As of day one, Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

2013 BIO International Convention Program Highlights

John Flavin

I’m thrilled to be attending the upcoming 2013 BIO International Convention that is coming to Chicago April 22-25. The educational sessions, networking, business forum, and exhibits are coming together to form the strongest Convention to date. Of course, I may be biased being a Chicago native but I can’t think of a better venue and backdrop for the rapidly evolving biotechnology industry. The City of Chicago is known for its architects and novel designs, a Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Auto Injectors & Pen Injectors: Differentiating Products in Asia Pacific

Steven Kaufman

Asia Pacific, with its mix of mature and emerging pharmaceutical markets and strong indigenous R&D capabilities, has no doubt already become a prominent driving force for the current and future global pharmaceutical industry with reports projecting the industry in this region to grow at a CAGR of 10 percent between 2012 and 2015. As the third largest pharmaceutical market following North America and Europe, Asia Pacific offers an immense potential for multinational pharmaceutical companies not Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,